Liverpool have agreed a deal to sign defender Marc Guéhi from Crystal Palace, sources have told ESPN.
The 25-year-old has been granted permission to undergo a medical in London after Liverpool saw a £35 million ($47m) bid accepted on Monday. He is set to sign a five-year contract running until the summer of 2030.
Talks have been ongoing between the two clubs for several weeks, with just one year remaining on Guéhi's Palace contract. The move comes after Palace boss Oliver Glasner insisted he wanted the centre-back to stay at Selhurst Park.
Speaking in a news conference following Palace's victory over Aston Villa -- in which Guehi scored -- on Sunday, Glasner said: "There is no deal. We can decide, he is our player and under contract. We can decide. It is up to us.
- LIVE BLOG: Follow the latest on transfer deadline day
- Men's grades: How we've rated the PL deals
- The completed transfers from the major football leagues
"The only one who decides if Marc has to stay is our chairman."
Guehi joined Palace from Chelsea in 2021 and has gone on to captain the side, making 155 appearances and helping the club to win their first major trophy in last season's FA Cup final.
He also has 23 senior caps for England and provides defensive reinforcement for Liverpool following the £35m departure of Jarell Quansah to Bayer Leverkusen.
Newer articles
Older articles
Gavaskar Calls for Kuldeep Yadav's Inclusion in 2nd Test Amid Bumrah Fitness Concerns, Cites Birmingham Pitch Conditions
Stokes Praises England Openers' Key Role in Record-Breaking Chase Against India
Black Caps Set for Blockbuster Home Summer Against Cricket Heavyweights: Australia, England, West Indies, and South Africa to Tour New Zealand
5 Warning Signs of Prediabetes You Might Be Missing
Former Selector Blasts India's Fielding Lapses After Test Defeat to England; 'Simple Catches Cost Us'
Nitish Rana Set for Delhi Comeback After Disappointing Uttar Pradesh Spell
Ederson Exits Man City for Fenerbahce, Paving the Way for Donnarumma's Etihad Arrival
Gambhir Stands by India's Lower Order Despite Test Collapse; Cites Missed Catches as Key Factor
India's First Dengue Vaccine: Phase 3 Trials Approach Finish Line, Promising Hope Against Deadly Virus
Rishabh Pant's Unorthodox Batting Revolutionizing Cricket, Claims Greg Chappell